Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like University of Tubingen Release: Neurosciences: A Stress Test For Men And Women February 5, 2017 Innocoll Announcement Relating To The Outcome Of The Court Sanction Hearing July 20, 2017 San Diego-based Biotech Expands for Future Growth and Top Talent August 6, 2017
